Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88.
Published August 3, 2022 · Recall initiated: June 27, 2022
Summary
FDA records drug Class II recall D-1291-2022, published August 3, 2022 and initiated June 27, 2022. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 9552 bottles; Lot: Lot: HAC1312A, EXP. 05/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIVALPROEX SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide in the USA
- UPC
- 0362756796836
- Lot
- Lot: HAC1312A, EXP. 05/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADivalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by:July 29, 2026
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDADivalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, ManufacturedAugust 31, 2022
- FDACrest 3D White Fluoride Anticavity Toothpaste, Advanced Triple Whitening, 0.243% sodium fluoride, Net Wt. 5.6August 3, 2022
- FDAInsulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDCAugust 3, 2022
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy'sFebruary 27, 2019
Questions about this recall
Was Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol- 389 350, Gujarat, India, NDC 62756-798-88. recalled?
Yes. FDA published recall D-1291-2022 on August 3, 2022. Reported hazard: Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIVALPROEX SODIUM. UPC: 0362756796836.